GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Waters Corp (BSP:WATC34) » Definitions » Short Interest

Waters (BSP:WATC34) Short Interest


View and export this data going back to 2019. Start your Free Trial

What is Waters Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Waters's Short Interest

For the Diagnostics & Research subindustry, Waters's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Waters's Short Interest Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Waters's Short Interest distribution charts can be found below:

* The bar in red indicates where Waters's Short Interest falls into.


Waters (BSP:WATC34) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Waters Corp (BSP:WATC34) » Definitions » Short Interest
Comparable Companies
ILMN LH DGX CRL ICLR RVTY EXAS MEDP MTD NTRA TSE:2309 TMO DHR IQV IDXX XSWX:LONN A SHSE:603259 XPAR:BIM XPAR:ERF
Traded in Other Exchanges
WAT:USA WAT:Mexico WAZ:Germany
Address
34 Maple Street, Milford, MA, USA, 01757
Website
https://www.waters.com
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2022, Waters generated 59% from pharmaceutical customers, 31% from industrial clients, and 10% from academic/government institutions.

Waters (BSP:WATC34) Headlines

No Headlines